Core Laboratories (NYSE:CLB – Get Free Report) announced its quarterly earnings results on Wednesday. The oil and gas company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.04, Briefing.com reports. Core Laboratories had a net margin of 5.44% and a return on equity of 15.20%. The firm had revenue of $134.40 million during the quarter, compared to the consensus estimate of $134.16 million. During the same period last year, the firm posted $0.22 EPS. The firm’s quarterly revenue was up 7.2% on a year-over-year basis. Core Laboratories updated its Q4 2024 guidance to 0.200-0.250 EPS and its Q4 guidance to $0.20-0.25 EPS.
Core Laboratories Stock Up 2.5 %
CLB traded up $0.48 during trading on Friday, reaching $19.42. The company had a trading volume of 11,011 shares, compared to its average volume of 432,710. The company has a market cap of $910.80 million, a P/E ratio of 21.51, a PEG ratio of 1.08 and a beta of 2.36. Core Laboratories has a 12 month low of $13.82 and a 12 month high of $25.13. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.39 and a quick ratio of 1.68. The business’s fifty day moving average price is $18.53 and its 200 day moving average price is $18.96.
Core Laboratories Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, November 25th. Investors of record on Monday, November 4th will be paid a dividend of $0.01 per share. The ex-dividend date is Monday, November 4th. This represents a $0.04 dividend on an annualized basis and a yield of 0.21%. Core Laboratories’s payout ratio is 4.55%.
Wall Street Analyst Weigh In
Check Out Our Latest Report on CLB
Core Laboratories Company Profile
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Recommended Stories
- Five stocks we like better than Core Laboratories
- What is the Hang Seng index?
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- How to Calculate Inflation Rate
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- The Downtrend in UPS Stock Isn’t Over Yet
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.